Madelon Maurice

@madelonmaurice.bsky.social

🚀 Big news from the Maurice lab! OutMARCH has secured an EIC Pathfinder grant to develop SureTACs, bispecific antibodies that degrade cancer driving membrane proteins, including previously undruggable targets. A new precision strategy to overcome therapy resistance in cancer. Thread 👇

Bild

Incredibly excited to join forces to develop new and unconventional approaches for #colorectalcancer treatment with the REWIRE-CAN team! @cancergrand.bsky.social @umcutrecht.bsky.social @oncodeinstitute.bsky.social @mauricelab.bsky.social

Cancer Grand Challenges@cancergrand.bsky.social · 5mo ago

📰 News announcement! www.cancergrandchallenges.org/new-teams-an... We’re thrilled to welcome five world-leading scientific teams, each awarded up to £20 million, to take on some of the toughest unanswered questions in #CancerResearch. Find out more about the teams and their challenges.